Home › Funds › TCG Crossover Management, LLC › OCUL

TCG Crossover Management, LLC position in OCUL

OCULAR THERAPEUTIX INC · Health Care

TCG Crossover Management, LLC reported holding 1,647,752 shares of OCUL (OCULAR THERAPEUTIX INC) in its Q2 2026 13F filing — a position valued at US$16.2M, representing 0.39% of its reported portfolio and ranking #43 among its reported holdings. TCG Crossover Management, LLC has disclosed OCUL holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.65M sh
Reported value held$16.18M
Portfolio Weight0.39%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's OCUL position evolved

TCG Crossover Management, LLC first disclosed a stake in OCUL in Q1 2024 at 5,319,148 shares (US$48.4M). The position peaked in Q3 2025 at 6,117,232 shares, worth US$71.5M. Across 10 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 1,647,752 shares valued at US$16.2M. Notable position changes include a 71% trim in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 5.32M $48.40M New
Q2 2024 5.32M $36.38M Hold
Q3 2024 5.32M $46.28M Hold
Q4 2024 5.32M $45.43M Hold
Q1 2025 5.32M $38.99M Hold
Q2 2025 5.32M $49.36M Hold
Q3 2025 6.12M $71.51M Add
Q4 2025 5.74M $69.69M Reduce
Q1 2026 1.65M $13.96M Reduce
Q2 2026 1.65M $16.18M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCUL and 13F data

OCUL (OCULAR THERAPEUTIX INC) is a Health Care company. 42 other funds we track also report a position in OCUL — the largest reported positions include Deep Track Capital, LP (US$193.3M), Avoro Capital Advisors LLC (US$123.1M), SUMMER ROAD LLC (US$119.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCUL

All OCUL fund holders →

FAQ

How long has TCG Crossover Management, LLC held OCUL?

TCG Crossover Management, LLC has disclosed OCUL holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is TCG Crossover Management, LLC's current position in OCUL?

As of Q2 2026, TCG Crossover Management, LLC holds 1.65M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $16.18M, representing 0.39% of its reported portfolio and ranking #43.

Has TCG Crossover Management, LLC been buying or selling OCUL?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in OCUL. The position peaked in Q3 2025 at 6.12M shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Deep Track Capital, LP, Avoro Capital Advisors LLC, SUMMER ROAD LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.